Terapia para xerostomía en pacientes geriátricos
Los sustitutos salivares y otros productos farmacológicos son comúnmente u como terapia para xerostomía en adultos mayores, Estos pacientes geriátricos suelen padecer directamente de hiposalivación por causa de una enfermedad sistémica o indirectamente por el consumo de algunos medicamentos. Se pret...
- Autores:
-
Rocha Buelvas, Anderson
- Tipo de recurso:
- Contribution to the magazine
- Fecha de publicación:
- 2009
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/53366
- Acceso en línea:
- https://hdl.handle.net/20.500.12494/53366
- Palabra clave:
- Xerostomía
Hiposalivación
Sustitutos salivales
Paciente geriátrico
Gerodontología.
Xerostomia
Hiposalivation
Saliva substitute
Geriatric patient
Gerodontology
- Rights
- openAccess
- License
- Atribución
id |
COOPER2_88dcb6f01f71ff4870e638b228ac98dc |
---|---|
oai_identifier_str |
oai:repository.ucc.edu.co:20.500.12494/53366 |
network_acronym_str |
COOPER2 |
network_name_str |
Repositorio UCC |
repository_id_str |
|
dc.title.none.fl_str_mv |
Terapia para xerostomía en pacientes geriátricos |
title |
Terapia para xerostomía en pacientes geriátricos |
spellingShingle |
Terapia para xerostomía en pacientes geriátricos Xerostomía Hiposalivación Sustitutos salivales Paciente geriátrico Gerodontología. Xerostomia Hiposalivation Saliva substitute Geriatric patient Gerodontology |
title_short |
Terapia para xerostomía en pacientes geriátricos |
title_full |
Terapia para xerostomía en pacientes geriátricos |
title_fullStr |
Terapia para xerostomía en pacientes geriátricos |
title_full_unstemmed |
Terapia para xerostomía en pacientes geriátricos |
title_sort |
Terapia para xerostomía en pacientes geriátricos |
dc.creator.fl_str_mv |
Rocha Buelvas, Anderson |
dc.contributor.author.none.fl_str_mv |
Rocha Buelvas, Anderson |
dc.subject.none.fl_str_mv |
Xerostomía Hiposalivación Sustitutos salivales Paciente geriátrico Gerodontología. |
topic |
Xerostomía Hiposalivación Sustitutos salivales Paciente geriátrico Gerodontología. Xerostomia Hiposalivation Saliva substitute Geriatric patient Gerodontology |
dc.subject.other.none.fl_str_mv |
Xerostomia Hiposalivation Saliva substitute Geriatric patient Gerodontology |
description |
Los sustitutos salivares y otros productos farmacológicos son comúnmente u como terapia para xerostomía en adultos mayores, Estos pacientes geriátricos suelen padecer directamente de hiposalivación por causa de una enfermedad sistémica o indirectamente por el consumo de algunos medicamentos. Se pretende reportar los hallazgos más importantes sobre la etiología y el manejo de la xerostomía en esta población, por consiguiente, se exponen la función de los sustitutos salivares y otras terapias farmacológicas como tratamiento para la misma. Por último, se concluye que el uso y la investigación de los sustitutos salivares son imprescindibles en Odontología. |
publishDate |
2009 |
dc.date.issued.none.fl_str_mv |
2009-01 |
dc.date.accessioned.none.fl_str_mv |
2023-11-17T17:28:35Z |
dc.date.available.none.fl_str_mv |
2023-11-17T17:28:35Z |
dc.type.none.fl_str_mv |
Artículo de divulgación |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_3e5a |
dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.redcol.none.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
http://purl.org/coar/resource_type/c_3e5a |
status_str |
publishedVersion |
dc.identifier.issn.none.fl_str_mv |
1900-3080 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12494/53366 |
dc.identifier.bibliographicCitation.none.fl_str_mv |
Rocha Buelvas, A. (2009). Terapia para xerostomía en pacientes geriátricos. Revista Nacional de Odontología, 5(8), 48-56. |
identifier_str_mv |
1900-3080 Rocha Buelvas, A. (2009). Terapia para xerostomía en pacientes geriátricos. Revista Nacional de Odontología, 5(8), 48-56. |
url |
https://hdl.handle.net/20.500.12494/53366 |
dc.relation.ispartofjournal.none.fl_str_mv |
Revista Nacional de Odontología |
dc.relation.references.none.fl_str_mv |
1. Porter SR, Scully C, Hegarty AM et al. An update of the etiology and management of xerostomia. Oral surg Oral med Oral pathol Oral Radiol Endod. 2004; 97: 28-46. 2. Pow EH, McMillan AS, Leung WK, Wong MC, Kwong DL. Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma. Clin Oral Investig. 2003; 7: 230-4. 3. Porter SR, Scully C. Adverse drug reactions in the mouth. Clin Dermatol. 2000; 18: 525-32. 4. Pajukoski H, Meurman JH, Halonen P, Sulkava R. Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92: 641-9. 5. Chuang SF. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004: 1-7. 6. Petersen PE, Bourgeois D, Bratthall D et al. Oral health information systems - towards measuring progress in oral health promotion and disease. Bull world health Organ. 2005; 83: 1-5. 7. Frost PM, Shirlaw PJ, Walter JD, Challacombe SJ. Patient preferences in a preliminary study comparing an intra-oral lubricating device with the usual dry mouth lubricating methods. Br Dent J. 2002; 193: 403-8. 8. Amosson CM, Teh BS, John Van T et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. International Journal of Radiation Oncology Biology Physics. 2003; 56: 136-44. 9. Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer.J Pain Symptom Manage. 2001; 22: 820-50. 10. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome. Oral Dis. 2002; 8: 130-40. 11. Mbopi-Keou FX, Belec L, Teo CG, Scully C, Porter SR. Synergism between HIV and other viruses in the mouth. Lancet Infect Dis. 2002; 2: 416-24. 12. Rostron J, Rogers S, Longman L, Kaney S, Field EA. Health related quality of life in patients with primary Sjögren's syndrome and xerostomia: a comparative study. Gerodontology. 2002; 19: 53-9. 13. Silvestre Donat FJ, Miralles Jordá L, Martínez Mihi V et al. Tratamiento de la boca seca: puesta al día. Med Oral. 2004; 9: 273-9. 14. Engelen L, Fontijn-Tekamp A, Van der Bilt A et al. The influence of product and oral characteristics on swallowing. Archives of oral biology. 2005; 30: 1-7. 15. Gallardo JM. Xerostomia: etiology, diagnosis and treatment. Rev Med Inst Seguro Soc. 2008; 46: 109-16. 16. Alves MB et al. Saliva substitute in xerostomic patients with primary Sjögren's syndromes a single-blind trial. Gerodontology. 2002; 19: 123-4. 17. Al-Hashimi I, Taylor SE. A new medication for treatment of dry mouth in Sjögren's syndrome. Tex Dent J. 2001; 118: 262-6. 18. Momm F, Guttenberger R. Treatment of xerostomia following radiotherapy: does age matter? Support Care Cancer 2002; 10: 505-8. 19. Budtz-Jørgensen E, Chung JP, Rapin CH. Nutrition and oral health. Best practice and research clinical gastroenterology. 2001; 15: 885-96. 20. Benjamin A, Bassichis MD, Marple MD. Dry mouth and nose in the older patient. Geriatrics. 2002; 57(10): 22-35. 21. Samarawickrama DY. Saliva substitutes: how effective and safe are they? Oral Dis. 2002; 8: 177-9. 22. Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. J Otolaryngol. 2000; 29: 28-34. 23. Vivino FB. The treatment of Sjögren's syndrome patients with pilocarpine-tablets. Scan J Rheumatol Suppl. 2001; 115: 1-9. 24. Koukourakis MI. Amifostine in clinical oncology: current use and future applications. Anticancer Drugs. 2002; 13: 181-209. 25. Horiot JC, Lipinski F, Schraub S, Maulard- Durdux C, Bensadoun RJ, Ardiet JM et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol. 2000; 55: 233-9. 26. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000; 14: 197-203. 27. Flink H, Tegelberg A, Lagerlöf F et al. Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Archives of oral biology. 2005; 50: 553-9. |
dc.rights.license.none.fl_str_mv |
Atribución |
dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Atribución http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.extent.none.fl_str_mv |
p. 48-56 |
dc.coverage.temporal.none.fl_str_mv |
Vol. 5, No. 8 |
dc.publisher.none.fl_str_mv |
Editorial Universidad Cooperativa de Colombia Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Odontología, Medellín y Envigado |
dc.publisher.program.none.fl_str_mv |
Odontología |
dc.publisher.place.none.fl_str_mv |
Medellín |
publisher.none.fl_str_mv |
Editorial Universidad Cooperativa de Colombia Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Odontología, Medellín y Envigado |
institution |
Universidad Cooperativa de Colombia |
bitstream.url.fl_str_mv |
https://repository.ucc.edu.co/bitstreams/86288bce-0f3e-4747-b917-22deb121ae45/download https://repository.ucc.edu.co/bitstreams/93a0e769-fb43-46e9-bd69-5be031161dc2/download https://repository.ucc.edu.co/bitstreams/71b2a08a-e7df-4c81-9697-b036a19a4f5b/download https://repository.ucc.edu.co/bitstreams/075ea9f1-2a59-47da-836e-2e47d2ba46d9/download |
bitstream.checksum.fl_str_mv |
3bce4f7ab09dfc588f126e1e36e98a45 0546aefbadd3283d77b9cfe7b005ea28 ba31b9b5642a63bd1d1cb16526a825ed f8e1be319559b8a6e889da0c961b8260 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad Cooperativa de Colombia |
repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
_version_ |
1814246781508124672 |
spelling |
Rocha Buelvas, AndersonVol. 5, No. 82023-11-17T17:28:35Z2023-11-17T17:28:35Z2009-011900-3080https://hdl.handle.net/20.500.12494/53366Rocha Buelvas, A. (2009). Terapia para xerostomía en pacientes geriátricos. Revista Nacional de Odontología, 5(8), 48-56.Los sustitutos salivares y otros productos farmacológicos son comúnmente u como terapia para xerostomía en adultos mayores, Estos pacientes geriátricos suelen padecer directamente de hiposalivación por causa de una enfermedad sistémica o indirectamente por el consumo de algunos medicamentos. Se pretende reportar los hallazgos más importantes sobre la etiología y el manejo de la xerostomía en esta población, por consiguiente, se exponen la función de los sustitutos salivares y otras terapias farmacológicas como tratamiento para la misma. Por último, se concluye que el uso y la investigación de los sustitutos salivares son imprescindibles en Odontología.The saliva substitutes and others pharmacologic products are the most commonly used as xerostomia therapy in elderly patients. These geriatric patients directly suffer from hiposalivation with systemic diseases or indirectly with some medicaments intake. It tries to report the most important findings about the etiology and management of the xerostomin in this population. consequently it shows the functions of the saliva substitutes and other pharmacologic therapies as treatment for the same. Later, it was concluded that research of the saliva substitutes is essential in dentistry.p. 48-56Editorial Universidad Cooperativa de ColombiaUniversidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Odontología, Medellín y EnvigadoOdontologíaMedellínXerostomíaHiposalivaciónSustitutos salivalesPaciente geriátricoGerodontología.XerostomiaHiposalivationSaliva substituteGeriatric patientGerodontologyTerapia para xerostomía en pacientes geriátricosArtículo de divulgaciónhttp://purl.org/coar/resource_type/c_3e5ahttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionAtribucióninfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Revista Nacional de Odontología1. Porter SR, Scully C, Hegarty AM et al. An update of the etiology and management of xerostomia. Oral surg Oral med Oral pathol Oral Radiol Endod. 2004; 97: 28-46.2. Pow EH, McMillan AS, Leung WK, Wong MC, Kwong DL. Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma. Clin Oral Investig. 2003; 7: 230-4.3. Porter SR, Scully C. Adverse drug reactions in the mouth. Clin Dermatol. 2000; 18: 525-32.4. Pajukoski H, Meurman JH, Halonen P, Sulkava R. Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92: 641-9.5. Chuang SF. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004: 1-7.6. Petersen PE, Bourgeois D, Bratthall D et al. Oral health information systems - towards measuring progress in oral health promotion and disease. Bull world health Organ. 2005; 83: 1-5.7. Frost PM, Shirlaw PJ, Walter JD, Challacombe SJ. Patient preferences in a preliminary study comparing an intra-oral lubricating device with the usual dry mouth lubricating methods. Br Dent J. 2002; 193: 403-8.8. Amosson CM, Teh BS, John Van T et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. International Journal of Radiation Oncology Biology Physics. 2003; 56: 136-44.9. Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer.J Pain Symptom Manage. 2001; 22: 820-50.10. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome. Oral Dis. 2002; 8: 130-40.11. Mbopi-Keou FX, Belec L, Teo CG, Scully C, Porter SR. Synergism between HIV and other viruses in the mouth. Lancet Infect Dis. 2002; 2: 416-24.12. Rostron J, Rogers S, Longman L, Kaney S, Field EA. Health related quality of life in patients with primary Sjögren's syndrome and xerostomia: a comparative study. Gerodontology. 2002; 19: 53-9.13. Silvestre Donat FJ, Miralles Jordá L, Martínez Mihi V et al. Tratamiento de la boca seca: puesta al día. Med Oral. 2004; 9: 273-9.14. Engelen L, Fontijn-Tekamp A, Van der Bilt A et al. The influence of product and oral characteristics on swallowing. Archives of oral biology. 2005; 30: 1-7.15. Gallardo JM. Xerostomia: etiology, diagnosis and treatment. Rev Med Inst Seguro Soc. 2008; 46: 109-16.16. Alves MB et al. Saliva substitute in xerostomic patients with primary Sjögren's syndromes a single-blind trial. Gerodontology. 2002; 19: 123-4.17. Al-Hashimi I, Taylor SE. A new medication for treatment of dry mouth in Sjögren's syndrome. Tex Dent J. 2001; 118: 262-6.18. Momm F, Guttenberger R. Treatment of xerostomia following radiotherapy: does age matter? Support Care Cancer 2002; 10: 505-8.19. Budtz-Jørgensen E, Chung JP, Rapin CH. Nutrition and oral health. Best practice and research clinical gastroenterology. 2001; 15: 885-96.20. Benjamin A, Bassichis MD, Marple MD. Dry mouth and nose in the older patient. Geriatrics. 2002; 57(10): 22-35.21. Samarawickrama DY. Saliva substitutes: how effective and safe are they? Oral Dis. 2002; 8: 177-9.22. Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. J Otolaryngol. 2000; 29: 28-34.23. Vivino FB. The treatment of Sjögren's syndrome patients with pilocarpine-tablets. Scan J Rheumatol Suppl. 2001; 115: 1-9.24. Koukourakis MI. Amifostine in clinical oncology: current use and future applications. Anticancer Drugs. 2002; 13: 181-209.25. Horiot JC, Lipinski F, Schraub S, Maulard- Durdux C, Bensadoun RJ, Ardiet JM et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol. 2000; 55: 233-9.26. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000; 14: 197-203.27. Flink H, Tegelberg A, Lagerlöf F et al. Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Archives of oral biology. 2005; 50: 553-9.PublicationLICENSElicense.txtlicense.txttext/plain; charset=utf-84334https://repository.ucc.edu.co/bitstreams/86288bce-0f3e-4747-b917-22deb121ae45/download3bce4f7ab09dfc588f126e1e36e98a45MD51ORIGINAL2009_Rocha_terapia_xerostomia_pacientes.pdfArtículo de divulgaciónapplication/pdf182652https://repository.ucc.edu.co/bitstreams/93a0e769-fb43-46e9-bd69-5be031161dc2/download0546aefbadd3283d77b9cfe7b005ea28MD52TEXT2009_Rocha_terapia_xerostomia_pacientes.pdf.txt2009_Rocha_terapia_xerostomia_pacientes.pdf.txtExtracted texttext/plain36876https://repository.ucc.edu.co/bitstreams/71b2a08a-e7df-4c81-9697-b036a19a4f5b/downloadba31b9b5642a63bd1d1cb16526a825edMD53THUMBNAIL2009_Rocha_terapia_xerostomia_pacientes.pdf.jpg2009_Rocha_terapia_xerostomia_pacientes.pdf.jpgGenerated Thumbnailimage/jpeg8850https://repository.ucc.edu.co/bitstreams/075ea9f1-2a59-47da-836e-2e47d2ba46d9/downloadf8e1be319559b8a6e889da0c961b8260MD5420.500.12494/53366oai:repository.ucc.edu.co:20.500.12494/533662024-08-10 17:31:11.045open.accesshttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.comVU5JVkVSU0lEQUQgQ09PUEVSQVRJVkEgREUgQ09MT01CSUEKUkVQT1NJVE9SSU9TIElOU1RJVFVDSU9OQUxFUwpMSUNFTkNJQSBERSBVU08KClBvciBtZWRpbyBkZWwgcHJlc2VudGUgZG9jdW1lbnRvLCBlbCBBdXRvcihlcyksIG1heW9yIChlcykgZGUgZWRhZCwgcXVpZW4gZW4gYWRlbGFudGUgc2UgZGVub21pbmFyw6EgZWwgQVVUT1IsIGNvbmZpZXJlIGEgbGEgVU5JVkVSU0lEQUQgQ09PUEVSQVRJVkEgREUgQ09MT01CSUEsIGNvbiBOSVQuIDg2MC0wMjk5MjQtNywgdW5hIExJQ0VOQ0lBIERFIFVTTyBkZSBvYnJhLCBiYWpvIGxhcyBzaWd1aWVudGVzIGNvbmRpY2lvbmVzLgoKQ0zDgVVTVUxBUwoKUFJJTUVSQS4gT2JqZXRvLiBFTCBBVVRPUiBwb3IgZXN0ZSBhY3RvIGF1dG9yaXphIGxhIHV0aWxpemFjacOzbiBkZSBsYSBvYnJhLCBkZSBjb25mb3JtaWRhZCBjb24gbG8gZXN0aXB1bGFkbyBhIGNvbnRpbnVhY2nDs246IAoKKGEpIFBhcmEgZWZlY3RvcyBkZSBsYSBwcmVzZW50ZSBsaWNlbmNpYSBzZSBhdXRvcml6YSBsYSByZXByb2R1Y2Npw7NuIGRlIGxhIG9icmEgYW50ZXJpb3JtZW50ZSBjaXRhZGEsIGxhIGN1YWwgc2UgYWxvamFyw6EgZW4gZm9ybWF0byBkaWdpdGFsIGVuIGxhcyBwbGF0YWZvcm1hcyBvIHJlcG9zaXRvcmlvcyBhZG1pbmlzdHJhZG9zIHBvciBsYSBVTklWRVJTSURBRCBvIGVuIG90cm8gdGlwbyBkZSByZXBvc2l0b3Jpb3MgZXh0ZXJub3MgbyBww6FnaW5hcyB3ZWIgZXNjb2dpZG9zIHBvciBsYSBVTklWRVJTSURBRCwgcGFyYSBmaW5lcyBkZSBkaWZ1c2nDs24geSBkaXZ1bGdhY2nDs24uIEFkaWNpb25hbG1lbnRlLCBzZSBhdXRvcml6YSBhIHF1ZSBsb3MgdXN1YXJpb3MgaW50ZXJub3MgeSBleHRlcm5vcyBkZSBkaWNoYXMgcGxhdGFmb3JtYXMgbyByZXBvc2l0b3Jpb3MgcmVwcm9kdXpjYW4gbyBkZXNjYXJndWVuIGxhIG9icmEsIHNpbiDDoW5pbW8gZGUgbHVjcm8sIHBhcmEgZmluZXMgcHJpdmFkb3MsIGVkdWNhdGl2b3MgbyBhY2Fkw6ltaWNvczsgc2llbXByZSB5IGN1YW5kbyBubyBzZSB2aW9sZW4gYWN1ZXJkb3MgY29uIGVkaXRvcmVzLCBwZXJpb2RvcyBkZSBlbWJhcmdvIG8gYWN1ZXJkb3MgZGUgY29uZmlkZW5jaWFsaWRhZCBxdWUgYXBsaXF1ZW4uCgooYikgU2UgYXV0b3JpemEgbGEgY29tdW5pY2FjacOzbiBww7pibGljYSB5IGxhIHB1ZXN0YSBhIGRpc3Bvc2ljacOzbiBkZSBsYSBvYnJhIG1lbmNpb25hZGEsIGVuIGFjY2VzbyBhYmllcnRvLCBwYXJhIHN1IHV0aWxpemFjacOzbiBlbiBsYXMgcGxhdGFmb3JtYXMgbyByZXBvc2l0b3Jpb3MgYWRtaW5pc3RyYWRvcyBwb3IgbGEgVU5JVkVSU0lEQUQuCgooYykgTG8gYW50ZXJpb3IgZXN0YXLDoSBzdWpldG8gYSBsYXMgZGVmaW5pY2lvbmVzIGNvbnRlbmlkYXMgZW4gbGEgRGVjaXNpw7NuIEFuZGluYSAzNTEgZGUgMTk5MyB5IGxhIExleSAyMyBkZSAxOTgyLgoKClNFR1VOREEuIE9yaWdpbmFsaWRhZCB5IHJlY2xhbWFjaW9uZXMuIEVsIEFVVE9SIGRlY2xhcmEgcXVlIGxhIE9CUkEgZXMgb3JpZ2luYWwgeSBxdWUgZXMgZGUgc3UgY3JlYWNpw7NuIGV4Y2x1c2l2YSwgbm8gZXhpc3RpZW5kbyBpbXBlZGltZW50byBkZSBjdWFscXVpZXIgbmF0dXJhbGV6YSAoZW1iYXJnb3MsIHVzbyBkZSBtYXRlcmlhbCBwcm90ZWdpZG8gcG9yIGRlcmVjaG9zIGRlIGF1dG9yKSBwYXJhIGxhIGNvbmNlc2nDs24gZGUgbG9zIGRlcmVjaG9zIHByZXZpc3RvcyBlbiBlc3RlIGFjdWVyZG8uIEVsIEFVVE9SIHJlc3BvbmRlcsOhIHBvciBjdWFscXVpZXIgYWNjacOzbiBkZSByZWl2aW5kaWNhY2nDs24sIHBsYWdpbyB1IG90cmEgY2xhc2UgZGUgcmVjbGFtYWNpw7NuIHF1ZSBhbCByZXNwZWN0byBwdWRpZXJhIHNvYnJldmVuaXIuCgpURVJDRVJBLiBDb250cmFwcmVzdGFjacOzbi4gRWwgQVVUT1IgYXV0b3JpemEgYSBxdWUgc3Ugb2JyYSBzZWEgdXRpbGl6YWRhIGRlIGNvbmZvcm1pZGFkIGNvbiBsYSBjbMOhdXN1bGEgUFJJTUVSQSBkZSBmb3JtYSBncmF0dWl0YSwgZXMgZGVjaXIsIHF1ZSBsYSB1dGlsaXphY2nDs24gZGUgbGEgbWlzbWEgbm8gZ2VuZXJhIG5pbmfDum4gcGFnbyBvIHJlZ2Fsw61hcyBlbiBmYXZvciBkZSBlc3RlLgoKQ1VBUlRBLiBUaXR1bGFyaWRhZCBkZSBkZXJlY2hvcy4gRWwgcHJlc2VudGUgY29udHJhdG8gbm8gdHJhbnNmaWVyZSBsYSB0aXR1bGFyaWRhZCBkZSBsb3MgZGVyZWNob3MgcGF0cmltb25pYWxlcyBzb2JyZSBsYXMgb2JyYXMgYW50ZXJpb3JtZW50ZSBtZW5jaW9uYWRhcyBhIGxhIFVOSVZFUlNJREFELiDDmm5pY2FtZW50ZSBoYWNlIHJlbGFjacOzbiBhIHVuYSBsaWNlbmNpYSBubyBleGNsdXNpdmEgZW4gbG9zIHTDqXJtaW5vcyB5IGNvbmRpY2lvbmVzIGFudGVyaW9ybWVudGUgcGFjdGFkb3MuCgpRVUlOVEEuIENyw6lkaXRvcy4gTGEgVU5JVkVSU0lEQUQgc2UgY29tcHJvbWV0ZSBhIGRhciBhbCBBVVRPUiwgZWwgcmVjb25vY2ltaWVudG8gZGVudHJvIGNhZGEgZm9ybWEgZGUgdXRpbGl6YWNpw7NuIGVuIGxhIG9icmEuIExvcyBjcsOpZGl0b3MgZGViZW4gZmlndXJhciBlbiBjYWRhIHVubyBkZSBsb3MgZm9ybWF0b3MgbyByZWdpc3Ryb3MgZGUgcHVibGljYWNpw7NuLiBObyBjb25zdGl0dWlyw6EgdW5hIHZpb2xhY2nDs24gYSBsb3MgZGVyZWNob3MgbW9yYWxlcyBkZWwgYXV0b3IgbGEgbm8gcmVwcm9kdWNjacOzbiwgY29tdW5pY2FjacOzbiBvIGRlbcOhcyB1dGlsaXphY2lvbmVzIGRlIGxhIG9icmEuIExhIHV0aWxpemFjacOzbiBvIG5vIGRlIGxhIG9icmEsIGFzw60gY29tbyBzdSBmb3JtYSBkZSB1dGlsaXphY2nDs24gc2Vyw6EgZmFjdWx0YWQgZXhjbHVzaXZhIGRlIGxhIFVOSVZFUlNJREFELgogClNFWFRBLiBEdXJhY2nDs24geSB0ZXJyaXRvcmlvLiBMYSBwcmVzZW50ZSBsaWNlbmNpYSBkZSB1c28gcXVlIHNlIG90b3JnYSBhIGZhdm9yIGRlIGxhIFVOSVZFUlNJREFEIHRlbmRyw6EgdW5hIGR1cmFjacOzbiBlcXVpdmFsZW50ZSBhbCB0w6lybWlubyBkZSBwcm90ZWNjacOzbiBsZWdhbCBkZSBsYSBvYnJhIHkgcGFyYSB0b2RvcyBsb3MgcGHDrXNlcyBkZWwgbXVuZG8uCgpTw4lQVElNQS4gVXNvIGRlIENyZWF0aXZlIENvbW1vbnMuIEVsIEFVVE9SIGF1dG9yaXphcsOhIGxhIGRpZnVzacOzbiBkZSBzdSBjb250ZW5pZG8gYmFqbyB1bmEgbGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyBhdHJpYnVjacOzbiA0LjAgaW50ZXJuYWNpb25hbCwgcXVlIGRlYmVyw6EgaW5jbHVpcnNlIGVuIGVsIGNvbnRlbmlkby4gCgpPQ1RBVkEuIERlcmVjaG8gZGUgZXhjbHVzacOzbi4gQ2FkYSBhdXRvciBwdWVkZSBpbmRpY2FyIGVuIGVsIG1vbWVudG8gZGUgZGVww7NzaXRvIGRlbCBjb250ZW5pZG8gcXVlIGVsIHRleHRvIGNvbXBsZXRvIGRlIGxhIHByb2R1Y2Npw7NuIGFjYWTDqW1pY2EgbyBjaWVudMOtZmljYSBubyBlc3RlIGNvbiBhY2Nlc28gYWJpZXJ0byBlbiBlbCBSZXBvc2l0b3JpbyBJbnN0aXR1Y2lvbmFsIHBvciBtb3Rpdm9zIGRlIGNvbmZpZGVuY2lhbGlkYWQsIHBvcnF1ZSBzZSBlbmN1ZW50cmUgZW4gdsOtYXMgZGUgb2J0ZW5lciB1biBkZXJlY2hvIGRlIHByb3BpZWRhZCBpbmR1c3RyaWFsIG8gZXhpc3RpciBhY3VlcmRvcyBwcmV2aW9zIGNvbiB0ZXJjZXJvcyAoZWRpdG9yaWFsZXMsIHJldmlzdGFzIGNpZW50w61maWNhcywgb3RyYXMgaW5zdGl0dWNpb25lcykuIEVsIGF1dG9yIHNlIGNvbXByb21ldGUgYSBkZXBvc2l0YXIgbG9zIG1ldGFkYXRvcyBlIGluZm9ybWFyIGVsIHRpZW1wbyBkZSBlbWJhcmdvIGR1cmFudGUgZWwgY3VhbCBlbCB0ZXh0byBjb21wbGV0byB0ZW5kcsOhIGFjY2VzbyByZXN0cmluZ2lkby4gCgpOT1ZFTkEuIEVsIEFVVE9SIGFsIGFjZXB0YXIgZXN0YSBsaWNlbmNpYSBhZHVjZSBxdWUgZXN0YSBwcm9kdWNjacOzbiBzZSBkZXNhcnJvbGzDsyBlbiBlbCBwZXJpb2RvIGVuIHF1ZSBzZSBlbmN1ZW50cmEgY29uIHbDrW5jdWxvcyBjb24gTGEgVW5pdmVyc2lkYWQuCgpEw4lDSU1BLiBOb3JtYXMgYXBsaWNhYmxlcy4gUGFyYSBsYSBpbnRlcnByZXRhY2nDs24geSBjdW1wbGltaWVudG8gZGVsIHByZXNlbnRlIGFjdWVyZG8gbGFzIHBhcnRlcyBzZSBzb21ldGVuIGEgbGEgRGVjaXNpw7NuIEFuZGluYSAzNTEgZGUgMTk5MywgbGEgTGV5IDIzIGRlIDE5ODIgeSBkZW3DoXMgbm9ybWFzIGFwbGljYWJsZXMgZGUgQ29sb21iaWEuIEFkZW3DoXMsIGEgbGFzIG5vcm1hcyBJbnN0aXR1Y2lvbmFsZXMgcXVlIGFwbGlxdWVuLgoKTGEgcHJlc2VudGUgbGljZW5jaWEgc2UgYXV0b3JpemEgZW4gbGEgZmVjaGEgZGUgcHVibGljYWNpw7NuIGVuIGxvcyByZXBvc2l0b3Jpb3MgaW5zdGl0dWNpb25hbGVzLgo= |